Skip to content

Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic

Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness (BREATH): an RCT for Frontline Hospital and Long-term Care Home Staff Managing the COVID-19 Pandemic

Status
Terminated
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04368676
Acronym
BREATH
Enrollment
15
Registered
2020-04-30
Start date
2020-06-25
Completion date
2022-04-09
Last updated
2022-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compassion Fatigue, Healthcare Providers, Healthcare Workers, Job Stress, Psychological Trauma, Workplace Stress

Keywords

COVID-19, Coronavirus, Healthcare staff, Work stress, insomnia, anxiety, depression, resilience, mind-body intervention

Brief summary

This study will examine the feasibility of conducting an online Randomized Controlled Trial (RCT) in frontline hospital and long term care healthcare staff in managing COVID-19 patients in London, ON. The study will randomize participants to Sudarshan Kriya Yoga (SKY) or a Health Enhancement Program (HEP).

Detailed description

The COVID-19 pandemic continues to escalate as a global health threat, leading to devastating impacts on the healthcare system. Frontline healthcare workers are dealing with increased demands and fears for their own, as well as their family's safety. Adding to the stress is the limited ability to maintain social connectedness as physical distancing measures are in place. The investigators plan to conduct an open-label feasibility randomized controlled trial (RCT), comparing an online breath based yogic intervention called Sudarshan Kriya Yoga (SKY) (n=30) versus an online control mind-body intervention called the Health Enhancement Program (HEP) (n=30) in 60 hospital and long term care frontline staff that are managing COVID-19 patients. Participants will be blinded to the treatment hypothesis while data analyst will be blinded to treatment allocation. Both SKY and HEP will be taught online in two phases in the first week followed by weekly reinforcement sessions for the following 4 weeks. Feasibility measures will be assessed as well as self-rated measures of insomnia, anxiety, depression, and resilience. The investigators expect that it will be feasible to conduct an online RCT of two mind-body interventions, SKY and HEP, in staff managing the COVID-19 pandemic, and that the investigators will be able to remotely monitor safety and efficacy of these interventions.

Interventions

The SKY program is a standardized, easy to learn sequential breathing yoga consisting of regulated breathing techniques followed by a timed rhythmic breathing practice. Participants will learn various exercises including rhythmic breathing, gentle yoga, and guided meditation.

HEP is a structured group program designed to help participants with information and instruction how to lead a healthier life. Participants will be provided psychoeducation and support regarding healthy active living using techniques like music therapy, diet control, exercise, and monitoring these via journaling.

Sponsors

Art of Living Foundation
CollaboratorUNKNOWN
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Participants will be blinded to the treatment hypothesis while the data analyst will be blinded to treatment allocation.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Participants will be frontline hospital or long-term care home staff involved in the management of COVID-19 patients in Canada or The United States of America. 2. Participants will be aged 18 to 70. 3. Participants will be willing and able to attend, via WebEx software, the introductory phase of SKY or HEP, as well as at least two of the four weekly follow-up sessions 4. Have sufficient hearing to follow verbal instructions. 5. Have an adequate understanding of English. 6. Able to sit without physical discomfort for 60 minutes. 7. Not pregnant and willing to remain not pregnant for the duration of the study.

Exclusion criteria

1. Inability to independently provide informed consent. 2. Current suicidality as assessed by the suicide item of the Patient Health Questionnaire-9 scale. 3. History of bipolar disorder. 4. History of chronic PTSD. 5. History of schizophrenia or schizoaffective disorder. 6. Currently practice any type of formal meditation, mindfulness, or breathing techniques regularly (greater than 3 times per week). 7. History of complex PTSD.

Design outcomes

Primary

MeasureTime frameDescription
Unexpected costs1 yearThe total of unexpected costs will be calculated as a feasibility measure.
Rate of participant recruitment1 yearThe number of participants recruited per month will be calculated as a feasibility measure.
Rate of retention1 yearThe retention rate of participants will be calculated as a feasibility measure.
Completeness of data entry1 yearThe completeness of study assessments will be assessed as a feasibility measure by calculating the missing percentage of data in case report forms.
Cost of interventions1 yearThe cost of both study interventions will be calculated to assess the total study cost for interventions and the cost per participant. This information will be used as a feasibility measure.

Secondary

MeasureTime frameDescription
Change in Generalized Anxiety Disorder 7-item scaleChange from Week 0 to week 3 and to week 5The Generalized Anxiety Disorder 7-item scale (each scored 0-3) is a self-rated measure of anxiety and has been validated for the diagnosis of Generalized Anxiety Disorder in the adult population. Scores range from 0 to 21. Higher scores indicate greater anxiety symptoms (5-9, mild anxiety; 10-14, moderate anxiety; 15-21 severe anxiety).
Change in Patient Health Questionnaire 9Change from Week 0 to week 3 and to week 5The Patient Health Questionnaire (PHQ-9) is a 9-item, self-rated measure of depression which has been validated for screening a major depressive episode in adults. Total scores indicate various levels of depression: 0-4, no depression; 5-9, mild depression; 10-14, moderate depression; 15-19, moderately severe depression; 20-27, severe depression.
Change in Connor-Davidson Resilience ScaleChange from Week 0 to week 3 and to week 5The Connor-Davidson Resilience Scale (CD-RISC) is a brief self-rated assessment tool that comprises of 10 items, each rated on a 5-point Likert scale (0 = not true at all to 4 = true nearly all the time). Higher scores reflect greater resilience, which is a measure of one's ability to cope with stress. The scale demonstrated strong reliability and validity and has been studied in a variety of populations including medical personnel, nurses, social workers and physicians).
Change in Athens Insomnia ScaleChange from Week 0 to week 3 and to week 5The Athens Insomnia Scale will be used to assess insomnia. This scale is an 8-item, self-rated measure of the extent of sleep difficulties over the last 30 days with each item representing a different aspect of sleep (e.g. Overall Quality of Sleep). Ratings are from 0 to 4, with 0 being no difficulty with the item and 4 being the most difficulty with the item. Higher overall scores on this scale indicate higher difficulties with sleep.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026